Table 3.
No. of subjects (%) | |||||
Serology | Female* | Male* | Total* | p* | |
HIV | Negative | 138 (80.7) | 761 (82.7) | 899 (82.4) | 0.040 |
Positive | 29 (17.0) | 107 (11.6) | 136 (12.5) | ||
Unknown | 4 (2.3) | 52 (5.6) | 56 (5.1) | ||
HBV | Negative | 47 (27.5) | 195 (21.2) | 242 (22.1) | 0.096 |
Positive | 76 (44.4) | 385 (41.8) | 461 (42.2) | ||
Unknown | 6 (3.5) | 55 (6.0) | 61 (6.0) | ||
Vaccinated | 42 (24.6) | 285 (31.0) | 327 (30.0) | ||
HCV | Negative | 33 (19.3) | 209 (22.7) | 242 (22.2) | 0.806 |
Positive | 127 (74.3) | 657 (71.4) | 784 (71.9) | ||
Unknown | 11 (6.4) | 54 (5.9) | 65 (6.0) | ||
TPHA | Negative | 128 (74.9) | 679 (73.8) | 807 (74.0) | 0.060 |
Positive | 6 (3.5) | 11 (1.2) | 17 (1.5) | ||
Unknown | 37 (21.6) | 230 (25.0) | 267 (24.5) |
Percentages by column; *p-value of the chi-square test for association.